Daratumumab-containing Induction Effects on Stem Cells Mobilization, colLection and Engraftment in Newly Diagnosed Multiple MyelomA Patients.

Clinical trial NCT05835726 · COMPLETED

Trial details

NCT number: NCT05835726
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Myeloma Daratumumab Autologous Stem Cell Transplantation Leukapheresis

Start date: 2022-01-01
Primary completion: 2025-01-31
Enrollment: 188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.